Authors:
Maes, M
Capuron, L
Ravaud, A
Gualde, N
Bosmans, E
Egyed, B
Dantzer, R
Neveu, PJ
Citation: M. Maes et al., Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy, NEUROPSYCH, 24(2), 2001, pp. 130-140
Authors:
Capuron, L
Ravaud, A
Gualde, N
Bosmans, E
Dantzer, R
Maes, M
Neveu, PJ
Citation: L. Capuron et al., Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy, PSYCHONEURO, 26(8), 2001, pp. 797-808
Citation: L. Capuron et al., Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients, PSYCHOS MED, 63(3), 2001, pp. 376-386
Citation: L. Capuron et al., Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy, J CL ONCOL, 18(10), 2000, pp. 2143-2151
Citation: L. Capuron et A. Ravaud, Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state, N ENG J MED, 340(17), 1999, pp. 1370-1370